Dobutamine Injection, USP 250 mg/20 ml Vial

Dobutamine Injection, USP 250 mg/20 ml Vial

Dobutamine Injection is a direct-acting inotropic agent primarily used to treat patients with heart disease or after heart surgery. It stimulates the heart's beta receptors, enhancing cardiac output with minimal effects on heart rate and peripheral vascular resistance. This medication is essential for managing low cardiac output states, such as acute heart failure and cardiogenic shock.

• Direct-acting inotropic agent
• Stimulates beta receptors of the heart
• Enhances cardiac output
• Minimal increase in heart rate

• Concentration 250 mg/20 ml
• Form Injection Vial
• Onset of Action 1-2 minutes
• Duration of Action 10 minutes
• Half-life 2 minutes

Used in critical care units for inotropic support and afterload reduction in low cardiac output states.

Healthcare professionals in cardiology, emergency departments, and critical care units.

DBL is known for its high-quality pharmaceutical products, providing reliable solutions for critical care and emergency medicine.